Skip to main

Kintara Therapeutics

KTRA is nowHURA
KTRA logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Jul 26, 2025, the market cap for KTRA stock is $132.67M

The current P/E ratio for KTRA stock is -0.25

The 52-week high for KTRA stock is $7.93. The current KTRA stock price $undefined is 100.00% below its 52-week high

The 52-week low for KTRA stock is $1.80. The current KTRA stock price $undefined has increased 100.00% from its 52-week low

No, the KTRA stock does not pay dividends to its shareholders

The target price for KTRA stock is $7.33 based on the average of what a group of analyst think KTRA stock could be worth at a future date. This is not a prediction by Public.com

How to buy KTRA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KTRA stock

    Navigate to the Explore page. Then, type KTRA into the search bar. When you see KTRA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KTRA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Kintara Therapeutics Stock Earnings

The value each KTRA share was expected to gain vs. the value that each KTRA share actually gained.

Kintara Therapeutics (KTRA) reported Q1 2024 earnings per share (EPS) of -$64.05, missing estimates of -$20.30 by 215.52%. In the same quarter last year, Kintara Therapeutics's earnings per share (EPS) was -$122.50. Kintara Therapeutics is expected to release next earnings on 05/14/2024, with an earnings per share (EPS) estimate of $0.

Buy Kintara Therapeutics (KTRA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.